Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

VEGFR inhibitor with potent antitumor activity alone and in combination

April 18, 2007

LY-2401401, a new multikinase inhibitor, presented at the AACR meeting

April 18, 2007

Multikinase inhibitor from Amgen with antiangiogenic and antitumor activity

April 18, 2007

Syndax licenses selective HDAC inhibitor from Bayer Schering Pharma

April 18, 2007

Orally bioavailable anthracycline penetrates the CNS in mice

April 18, 2007

Good safety and pharmacokinetic profile for multiple-dose PTC-299 in humans

April 17, 2007

Phase I results reported at AACR meeting for brain-penetrating doxorubicin analogue

April 17, 2007

QBI-139, an EVade(TM) ribonuclease variant, proves safe in rodents

April 17, 2007

ECE-1 as a novel target in breast cancer therapy

April 17, 2007

PI-88 improves disease-free survival in liver cancer patients after surgery

April 17, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...